Concepedia

Gabriel Abril-Rodríguez

GA

Statistics

Publications

16

Citations

5.3K

H-Index

16

Active since

2016

Affiliations

University of California, Los Angeles(Current)

Parker Institute for Cancer Immunotherapy

UCLA Health

UCLA Jonsson Comprehensive Cancer Center

University of Lausanne

Gabriel Abril-Rodríguez is an author at University of California, Los Angeles specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2016–2024

16

Publications

16

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

Jesse M. Zaretsky, Ángel García-Díaz, Daniel Sanghoon Shin et al. · New England Journal of Medicine · 2016 · 3.2K citations · Full text

, , +17

Genetic Mechanisms of Immune Evasion in Colorectal Cancer

Catherine S. Grasso, Marios Giannakis, Daniel K. Wells et al. · Cancer Discovery · 2018 · 550 citations · Full text

, , +17

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko et al. · Cancer Cell · 2020 · 383 citations · Full text

, , +14

SnapShot: Immune Checkpoint Inhibitors

Gabriel Abril-Rodríguez, Antoni Ribas · Cancer Cell · 2017 · 318 citations

, , +12

Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy

Cristina Puig-Saus, Barbara Sennino, Songming Peng et al. · Nature · 2023 · 202 citations · Full text

, , +14

1–5 of 16